Regulatory approval is a necessary condition for commercial success, not a sufficient one. In an environment of intensifying payer scrutiny, formulary restrictions, and value-based contracting, market access strategy has become as important as clinical development strategy — and brands that treat it as a post-approval activity consistently underperform at launch.
We help client teams build the evidence packages, value frameworks, pricing architectures, and payer engagement strategies that support durable commercial access — starting early enough to shape the evidence generation plan and continuing through in-market access management.
We map the commercial, Part D, Medicaid, and integrated system payer environment — identifying formulary placement, prior authorisation burdens, step therapy requirements, and access restrictions that will affect commercial performance at launch or in-market.
We build the payer-specific value story — grounded in clinical evidence, health economic modelling, and comparative effectiveness data — structured to address the specific decision criteria of commercial payers, PBMs, and government programmes.
We design the health economics and outcomes research plan that supports label language, payer submissions, and real-world evidence requirements — working backwards from access objectives to define which evidence gaps need to close and when.
We develop net pricing strategies, contract structures, and rebate frameworks that balance access objectives with revenue management — with gross-to-net modelling that gives finance and commercial leadership a clear view of access-revenue trade-offs at different price points.
We design the patient support infrastructure that bridges the gap between prescription and first fill — including benefit verification, prior authorisation support, copay assistance, and hub programme design — with a clear view of cost, compliance, and payer relationship implications.
We assess and close access readiness gaps ahead of launch — ensuring payer engagement strategies, access messaging, and account team capabilities are in place to secure formulary coverage in the critical months around approval.